The Emerging Role of TYRO3 as a Therapeutic Target in Cancer

by Sherri K. Smart, Eleana Vasileiadi, Xiaodong Wang, Deborah DeRyckere, Douglas K. Graham
Published 2018-11-01

Targeting the TAM Receptors in Leukemia

by Madeline G. Huey, Katherine A. Minson, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham
Published 2016-11-01

GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis

by Luke A. Law, Douglas K. Graham, Jorge Di Paola, Jorge Di Paola, Brian R. Branchford, Brian R. Branchford
Published 2018-05-01

Prolonged exposure to a Mer ligand in leukemia: Gas6 favors expression of a partial Mer glycoform and reveals a novel role for Mer in the nucleus.

by Justine Migdall-Wilson, Christine Bates, Jennifer Schlegel, Luis Brandão, Rachel M A Linger, Deborah DeRyckere, Douglas K Graham
Published 2012-01-01

MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.

by Alexandra Sufit, Alisa B Lee-Sherick, Deborah DeRyckere, Manali Rupji, Bhakti Dwivedi, Marileila Varella-Garcia, Angela M Pierce, Jeanne Kowalski, Xiaodong Wang, Stephen V Frye, H Shelton Earp, Amy K Keating, Douglas K Graham
Published 2016-01-01

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity

by Alisa B. Lee-Sherick, Kristen M. Jacobsen, Curtis J. Henry, Madeline G. Huey, Rebecca E. Parker, Lauren S. Page, Amanda A. Hill, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Craig T. Jordan, Deborah DeRyckere, Douglas K. Graham
Published 2020-12-01